Gastric ulceration occurring during indomethacin therapy

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain and inflammation.
• NSAIDs are known to cause gastrointestinal side effects, including peptic ulceration.

Purpose of the Study:

• To investigate the manifestations and outcomes of peptic ulceration in patients treated with indomethacin.
• To determine the relationship between indomethacin use and the development of peptic ulcers.

Main Methods:

• Observational study of patients experiencing dyspeptic symptoms, gastrointestinal bleeding, or anemia while on indomethacin therapy.
• Radiological assessment to identify and characterize peptic ulcers.
• Clinical monitoring of symptom resolution and ulcer healing after drug withdrawal.

Main Results:

• Dyspeptic symptoms, gastrointestinal bleeding, and anemia were identified as potential indicators of peptic ulceration in indomethacin users.
• Peptic ulcers associated with indomethacin occurred with both capsule and suppository formulations.
• Ulcers were frequently located in the prepyloric region and sometimes mimicked malignancy.
• Discontinuation of indomethacin led to rapid symptom relief and radiological evidence of ulcer healing.

Conclusions:

• Peptic ulceration is a significant risk associated with indomethacin therapy, regardless of administration route.
• Prompt recognition and withdrawal of indomethacin are crucial for effective management and healing of associated ulcers.
• The prepyloric location of these ulcers warrants careful diagnostic consideration to rule out malignancy.